» Articles » PMID: 25753668

Genome-wide CIITA-binding Profile Identifies Sequence Preferences That Dictate Function Versus Recruitment

Overview
Specialty Biochemistry
Date 2015 Mar 11
PMID 25753668
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

The class II transactivator (CIITA) is essential for the expression of major histocompatibility complex class II (MHC-II) genes; however, the role of CIITA in gene regulation outside of MHC-II biology is not fully understood. To comprehensively map CIITA-bound loci, ChIP-seq was performed in the human B lymphoblastoma cell line Raji. CIITA bound 480 sites, and was significantly enriched at active promoters and enhancers. The complexity of CIITA transcriptional regulation of target genes was analyzed using a combination of CIITA-null cells, including a novel cell line created using CRISPR/Cas9 tools. MHC-II genes and a few novel genes were regulated by CIITA; however, most other genes demonstrated either diminished or no changes in the absence of CIITA. Nearly all CIITA-bound sites were within regions containing accessible chromatin, and CIITA's presence at these sites was associated with increased histone H3K27 acetylation, suggesting that CIITA's role at these non-regulated loci may be to poise the region for subsequent regulation. Computational genome-wide modeling of the CIITA bound XY box motifs provided constraints for sequences associated with CIITA-mediated gene regulation versus binding. These data therefore define the CIITA regulome in B cells and establish sequence specificities that predict activity for an essential regulator of the adaptive immune response.

Citing Articles

Deletion of metal transporter Zip14 reduces major histocompatibility complex II expression in murine small intestinal epithelial cells.

Jimenez-Rondan F, Ruggiero C, Riva A, Yu F, Stafford L, Cross T Proc Natl Acad Sci U S A. 2025; 122(1):e2422321121.

PMID: 39793074 PMC: 11725848. DOI: 10.1073/pnas.2422321121.


A Ménage à trois: NLRC5, immunity, and metabolism.

Brunschwiler F, Nakka S, Guerra J, Guarda G Front Immunol. 2024; 15:1426620.

PMID: 39035010 PMC: 11257985. DOI: 10.3389/fimmu.2024.1426620.


IRF8-mutant B cell lymphoma evades immunity through a CD74-dependent deregulation of antigen processing and presentation in MHCII complexes.

Qiu Z, Khalife J, Ethiraj P, Jaafar C, Lin A, Holder K Sci Adv. 2024; 10(28):eadk2091.

PMID: 38996030 PMC: 11244530. DOI: 10.1126/sciadv.adk2091.


Engineering immune-evasive allogeneic cellular immunotherapies.

Martin K, Hammer Q, Perica K, Sadelain M, Malmberg K Nat Rev Immunol. 2024; 24(9):680-693.

PMID: 38658708 DOI: 10.1038/s41577-024-01022-8.


Combining different CRISPR nucleases for simultaneous knock-in and base editing prevents translocations in multiplex-edited CAR T cells.

Glaser V, Flugel C, Kath J, Du W, Drosdek V, Franke C Genome Biol. 2023; 24(1):89.

PMID: 37095570 PMC: 10123993. DOI: 10.1186/s13059-023-02928-7.


References
1.
Kent W, Zweig A, Barber G, Hinrichs A, Karolchik D . BigWig and BigBed: enabling browsing of large distributed datasets. Bioinformatics. 2010; 26(17):2204-7. PMC: 2922891. DOI: 10.1093/bioinformatics/btq351. View

2.
Zhou X, Jiang Y, Lu L, Ding Q, Jiao Z, Zhou Y . MHC class II transactivator represses human IL-4 gene transcription by interruption of promoter binding with CBP/p300, STAT6 and NFAT1 via histone hypoacetylation. Immunology. 2007; 122(4):476-85. PMC: 2266042. DOI: 10.1111/j.1365-2567.2007.02674.x. View

3.
Ting J, Trowsdale J . Genetic control of MHC class II expression. Cell. 2002; 109 Suppl:S21-33. DOI: 10.1016/s0092-8674(02)00696-7. View

4.
Westerheide S, Louis-Plence P, Ping D, He X, Boss J . HLA-DMA and HLA-DMB gene expression functions through the conserved S-X-Y region. J Immunol. 1997; 158(10):4812-21. View

5.
Choi N, Majumder P, Boss J . Regulation of major histocompatibility complex class II genes. Curr Opin Immunol. 2010; 23(1):81-7. PMC: 3033992. DOI: 10.1016/j.coi.2010.09.007. View